SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-000693
Filing Date
2019-01-04
Accepted
2019-01-04 17:09:16
Documents
9
Period of Report
2019-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv510157_8k.htm 8-K 42549
2 EXHIBIT 2.1 tv510157_ex2-1.htm EX-2.1 690839
3 EXHIBIT 10.1 tv510157_ex10-1.htm EX-10.1 59627
4 EXHIBIT 10.2 tv510157_ex10-2.htm EX-10.2 59684
5 EXHIBIT 10.3 tv510157_ex10-3.htm EX-10.3 23635
6 EXHIBIT 10.4 tv510157_ex10-4.htm EX-10.4 23232
7 EXHIBIT 99.1 tv510157_ex99-1.htm EX-99.1 24344
8 GRAPHIC image_001.jpg GRAPHIC 3385
9 GRAPHIC image_002.jpg GRAPHIC 3406
  Complete submission text file 0001144204-19-000693.txt   934798
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 19511022
SIC: 2836 Biological Products, (No Diagnostic Substances)